Related Experiment Videos
[Coronary artery ectasia: a therapeutic dilemma]
Albert Pagel1, Moshe Horovitz, Yoav Michovich
1Department of Internal Medicine C, Assaf Harofeh Medical Center, Zerifin, Israel.
Insights
Coronary artery ectasia (CAE), an abnormal widening of coronary arteries, is increasingly diagnosed. Its causes, risks, and optimal management remain unclear, necessitating further research.
Area of Science:
- Cardiology
- Vascular Biology
Context:
- Coronary artery ectasia (CAE) is characterized by abnormal dilatation of the coronary artery wall.
- The incidence of CAE has increased due to more frequent coronary angiographies and invasive cardiac procedures.
- Etiology, prognostic significance, and associated morbidity of CAE are not well-established.
Purpose:
- To review the current understanding of coronary artery ectasia.
- To discuss the potential causes, including atherosclerosis and secondary factors.
- To highlight the association of CAE with coronary morbid events and the ongoing management debates.
Summary:
- Atherosclerosis is considered the primary cause of idiopathic CAE.
- Secondary CAE may result from exposure to vasodilatory substances or therapeutic interventions.
- CAE is linked to increased risks of coronary spasm, dissection, and thrombus formation.
Impact:
- Uncertainty regarding CAE's contribution to morbidity fuels debate on patient management.
- Further research, including prospective therapeutic trials, is crucial for clarifying CAE's role and guiding treatment strategies.
- Establishing clear guidelines for CAE management will improve patient outcomes and reduce cardiovascular events.
Abstract:
Coronary artery ectasia (CAE) is an abnormal dilatation of the coronary artery wall. The growing number of coronary angiographies and other invasive cardiologic procedures increased the documented incidence of CAE. There is no consensus about the etiology, prognostic significance and morbidity related to this phenomenon. Atherosclerosis is most probably the main cause of primary or idiopathic ectasia. In addition, it is postulated that chronic exposure to vasodilatatory substances, and therapeutic angioplastic procedures may mediate secondary ectasia. CAE is associated with increased coronary morbidity such as coronary spasm, dissection and thrombus formation. However, its relative contribution to coronary morbidity remains unclear. This uncertainty underlies the current dispute regarding the appropriate management and treatment of patients with CAE. Further studies including prospective therapeutic trials are needed to provide answers to these pending complex questions.